Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.610
-0.050 (-3.01%)
At close: Feb 21, 2025, 4:00 PM
1.650
+0.040 (2.48%)
After-hours: Feb 21, 2025, 7:57 PM EST
Ventyx Biosciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Ventyx Biosciences stock have an average target of 11.33, with a low estimate of 9.00 and a high estimate of 14. The average target predicts an increase of 603.73% from the current stock price of 1.61.
Analyst Consensus: Buy
* Price targets were last updated on Nov 8, 2024.
Analyst Ratings
The average analyst rating for Ventyx Biosciences stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 4 | 4 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 5 | 5 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +272.67% | Nov 11, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +459.01% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +272.67% | Oct 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +272.67% | Sep 23, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.14
from -3.30
EPS Next Year
-2.25
from -2.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 96.3M | |||
Avg | n/a | n/a | 15.6M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -2.10 | -1.85 | -1.33 | |||
Avg | -2.14 | -2.25 | -1.96 | |||
Low | -2.14 | -3.36 | -2.58 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.